PL2976101T3 - Sposób leczenia - Google Patents

Sposób leczenia

Info

Publication number
PL2976101T3
PL2976101T3 PL14711232T PL14711232T PL2976101T3 PL 2976101 T3 PL2976101 T3 PL 2976101T3 PL 14711232 T PL14711232 T PL 14711232T PL 14711232 T PL14711232 T PL 14711232T PL 2976101 T3 PL2976101 T3 PL 2976101T3
Authority
PL
Poland
Prior art keywords
treatment
Prior art date
Application number
PL14711232T
Other languages
English (en)
Inventor
Yaela Baine
Jacqueline Miller
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50336313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2976101(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of PL2976101T3 publication Critical patent/PL2976101T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Virology (AREA)
PL14711232T 2013-03-18 2014-03-17 Sposób leczenia PL2976101T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361802918P 2013-03-18 2013-03-18
US201361874008P 2013-09-05 2013-09-05
PCT/EP2014/055355 WO2014147044A1 (en) 2013-03-18 2014-03-17 Method of treatment
EP14711232.0A EP2976101B1 (en) 2013-03-18 2014-03-17 Method of treatment

Publications (1)

Publication Number Publication Date
PL2976101T3 true PL2976101T3 (pl) 2021-03-08

Family

ID=50336313

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14711232T PL2976101T3 (pl) 2013-03-18 2014-03-17 Sposób leczenia

Country Status (21)

Country Link
US (1) US11883478B2 (pl)
EP (1) EP2976101B1 (pl)
JP (2) JP6747968B2 (pl)
KR (1) KR20150121265A (pl)
CN (1) CN105188743A (pl)
AU (1) AU2014234408B2 (pl)
BE (1) BE1021934B1 (pl)
BR (1) BR112015024014A2 (pl)
CA (1) CA2903322C (pl)
CY (1) CY1123600T1 (pl)
DK (1) DK2976101T3 (pl)
EA (1) EA034380B1 (pl)
ES (1) ES2830035T3 (pl)
HU (1) HUE051592T2 (pl)
IL (1) IL241096B (pl)
MX (1) MX382165B (pl)
PL (1) PL2976101T3 (pl)
PT (1) PT2976101T (pl)
SG (2) SG11201506810RA (pl)
SI (1) SI2976101T1 (pl)
WO (1) WO2014147044A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102906912B1 (ko) * 2016-09-02 2026-01-05 사노피 파스퇴르 인크 네이세리아 메닌기티디스 백신
WO2019084632A1 (en) * 2017-11-06 2019-05-09 The Crown in right of the State of New South Wales acting through the Department of Primary Industries as an office of the Department of Industry Vaccine
CN110652585B (zh) * 2018-10-26 2023-05-26 武汉博沃生物科技有限公司 多糖-蛋白缀合物免疫制剂及其制备与应用
US12533418B2 (en) * 2019-11-22 2026-01-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018637B2 (en) 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
OA12590A (en) * 2001-01-23 2006-06-08 Aventis Pasteur Multivalent meningococcal polysaccharide-protein conjugate vaccine.
GB0409745D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
AU2012203419B2 (en) * 2005-06-27 2014-06-26 Glaxosmithkline Biologicals S.A. Immunogenic composition
US8398983B2 (en) * 2005-06-27 2013-03-19 Glaxosmithkline Biologicals, S.A. Immunogenic composition
JP2009520771A (ja) * 2005-12-23 2009-05-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム コンジュゲートワクチン
PL2004225T3 (pl) 2006-03-22 2012-09-28 Novartis Ag Schematy immunizacji koniugatami meningokokowymi

Also Published As

Publication number Publication date
IL241096B (en) 2021-05-31
JP6747968B2 (ja) 2020-08-26
ES2830035T3 (es) 2021-06-02
BR112015024014A2 (pt) 2017-07-18
CY1123600T1 (el) 2022-03-24
SG11201506810RA (en) 2015-10-29
CA2903322C (en) 2023-09-05
KR20150121265A (ko) 2015-10-28
WO2014147044A1 (en) 2014-09-25
EA034380B1 (ru) 2020-01-31
MX382165B (es) 2025-03-13
SG10201710137QA (en) 2018-01-30
IL241096A0 (en) 2015-11-30
US20160279225A1 (en) 2016-09-29
JP2016515539A (ja) 2016-05-30
CN105188743A (zh) 2015-12-23
AU2014234408A1 (en) 2015-10-22
HUE051592T2 (hu) 2021-03-01
EA201591468A1 (ru) 2016-04-29
DK2976101T3 (da) 2020-11-23
BE1021934B1 (fr) 2016-01-27
SI2976101T1 (sl) 2021-01-29
MX2015013401A (es) 2016-01-08
AU2014234408B2 (en) 2017-04-20
EP2976101A1 (en) 2016-01-27
PT2976101T (pt) 2020-11-12
US11883478B2 (en) 2024-01-30
EP2976101B1 (en) 2020-08-19
JP2019142898A (ja) 2019-08-29
CA2903322A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
ZA201505956B (en) Methods of treating melanoma
GB201401248D0 (en) Method of manufacture
ZA201506534B (en) Method of treating hair
SG11201508878WA (en) Methods of treating cancer
GB201304872D0 (en) Treatment
IL242678B (en) A method for treating intracellular infection
ZA201507762B (en) Methods of treating cancer
GB201308466D0 (en) Improved process for treatment of minewater
ZA201507475B (en) Method for the treatment of gas
GB201305231D0 (en) Method of Manufacture
IL241096B (en) Treatment methods
GB2518928B (en) Method of depilation
PL3082860T3 (pl) Sposób leczenia ran
EP2985265A4 (en) PROCESS FOR TREATING RESIDUAL WATER
GB201307310D0 (en) Treatment
PL3041506T3 (pl) Sposób leczenia
ZA201601626B (en) Treatment of gases
SG11201602010VA (en) Heat treatment method
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment
AU2013904712A0 (en) Method of Treatment
AU2013904170A0 (en) Method of treatment
IL245100A0 (en) Methods for treating stomatitis associated with m-tor inhibitors
AU2013901359A0 (en) Methods of Treatment
GB201311291D0 (en) Method of manufacture